Golgi protein ACBD3 mediates neurotoxicity associated with huntington's disease

Cell Reports

Volumn 4, Issue 5, 2013, Pages 890-897

  Sbodio, JuanI ^a   Paul, BinduD ^a   Machamer, CarolynE ^a   Snyder, SolomonH ^a,b,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYL COENZYME A BINDING DOMAIN CONTAINING 3 PROTEIN; CELL PROTEIN; FARNESYL TRANS TRANSFERASE; GLUTATHIONE; HUNTINGTIN; RHES PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL STRESS; CONTROLLED STUDY; CORPUS STRIATUM; CYTOTOXICITY; EMBRYO; ENDOPLASMIC RETICULUM; GOLGI COMPLEX; HUMAN; HUMAN CELL; HUNTINGTON CHOREA; MITOCHONDRION; MOUSE; NERVE DEGENERATION; NEUROTOXICITY; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; UPREGULATION;

MUS;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; GTP-BINDING PROTEINS; HEK293 CELLS; HUMANS; HUNTINGTON DISEASE; MEMBRANE PROTEINS; MICE; NERVE TISSUE PROTEINS; NEURONS; RNA, SMALL INTERFERING; TRANSFECTION; UP-REGULATION;

EID: 84884138290     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2013.08.001     Document Type: Article

References (32)

1. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993, 72:971-983. The Huntington's Disease Collaborative Research Group.
2. Baiamonte B.A., Lee F.A., Brewer S.T., Spano D., LaHoste G.J. Attenuation of Rhes activity significantly delays the appearance of behavioral symptoms in a mouse model of Huntington's disease. PLoS ONE 2013, 8:e53606.
3. Carroll J.B., Warby S.C., Southwell A.L., Doty C.N., Greenlee S., Skotte N., Hung G., Bennett C.F., Freier S.M., Hayden M.R. Potent and selective antisense oligonucleotides targeting single-nucleotide polymorphisms in the Huntington disease gene / allele-specific silencing of mutant huntingtin. Mol. Ther. 2011, 19:2178-2185.
4. Cheah J.H., Kim S.F., Hester L.D., Clancy K.W., Patterson S.E., Papadopoulos V., Snyder S.H. NMDA receptor-nitric oxide transmission mediates neuronal iron homeostasis via the GTPase Dexras1. Neuron 2006, 51:431-440.
5. Chen Y., Khan R.S., Cwanger A., Song Y., Steenstra C., Bang S., Cheah J.H., Dunaief J., Shindler K.S., Snyder S.H., Kim S.F. Dexras1, a small GTPase, is required for glutamate-NMDA neurotoxicity. J.Neurosci. 2013, 33:3582-3587.
6. del Toro D., Canals J.M., Ginés S., Kojima M., Egea G., Alberch J. Mutant huntingtin impairs the post-Golgi trafficking of brain-derived neurotrophic factor but not its Val66Met polymorphism. J.Neurosci. 2006, 26:12748-12757.
7. DiFiglia M., Sapp E., Chase K., Schwarz C., Meloni A., Young C., Martin E., Vonsattel J.P., Carraway R., Reeves S.A., et al. Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons. Neuron 1995, 14:1075-1081.
8. Fan J., Liu J., Culty M., Papadopoulos V. Acyl-coenzyme A binding domain containing 3 (ACBD3; PAP7; GCP60): an emerging signaling molecule. Prog. Lipid Res. 2010, 49:218-234.
9. Fang M., Jaffrey S.R., Sawa A., Ye K., Luo X., Snyder S.H. Dexras1: a G protein specifically coupled to neuronal nitric oxide synthase via CAPON. Neuron 2000, 28:183-193.
10. Gonatas N.K., Stieber A., Gonatas J.O. Fragmentation of the Golgi apparatus in neurodegenerative diseases and cell death. J.Neurol. Sci. 2006, 246:21-30.
11. Greninger A.L., Knudsen G.M., Betegon M., Burlingame A.L., Derisi J.L. The 3A protein from multiple picornaviruses utilizes the golgi adaptor protein ACBD3 to recruit PI4KIIIβ. J.Virol. 2012, 86:3605-3616.
12. Johri A., Beal M.F. Mitochondrial dysfunction in neurodegenerative diseases. J.Pharmacol. Exp. Ther. 2012, 342:619-630.
13. Kemppainen R.J., Behrend E.N. Dexamethasone rapidly induces a novel ras superfamily member-related gene in AtT-20 cells. J.Biol. Chem. 1998, 273:3129-3131.
14. Li H., Degenhardt B., Tobin D., Yao Z.X., Tasken K., Papadopoulos V. Identification, localization, and function in steroidogenesis of PAP7: a peripheral-type benzodiazepine receptor- and PKA (RIalpha)-associated protein. Mol. Endocrinol. 2001, 15:2211-2228.
15. Li J.Y., Popovic N., Brundin P. The use of the R6 transgenic mouse models of Huntington's disease in attempts to develop novel therapeutic strategies. NeuroRx 2005, 2:447-464.
16. Liu J., Rone M.B., Papadopoulos V. Protein-protein interactions mediate mitochondrial cholesterol transport and steroid biosynthesis. J.Biol. Chem. 2006, 281:38879-38893.
17. Luthi-Carter R., Hanson S.A., Strand A.D., Bergstrom D.A., Chun W., Peters N.L., Woods A.M., Chan E.Y., Kooperberg C., Krainc D., et al. Dysregulation of gene expression in the R6/2 model of polyglutamine disease: parallel changes in muscle and brain. Hum. Mol. Genet. 2002, 11:1911-1926.
18. Mealer R.G., Subramaniam S., Snyder S.H. Rhes deletion is neuroprotective in the 3-nitropropionic acid model of Huntington's disease. J.Neurosci. 2013, 33:4206-4210.
19. Midzak A., Rone M., Aghazadeh Y., Culty M., Papadopoulos V. Mitochondrial protein import and the genesis of steroidogenic mitochondria. Mol. Cell. Endocrinol. 2011, 336:70-79.
20. Nakagomi S., Barsoum M.J., Bossy-Wetzel E., Sütterlin C., Malhotra V., Lipton S.A. A Golgi fragmentation pathway in neurodegeneration. Neurobiol. Dis. 2008, 29:221-231.
21. Oku M., Tanakura S., Uemura A., Sohda M., Misumi Y., Taniguchi M., Wakabayashi S., Yoshida H. Novel cis-acting element GASE regulates transcriptional induction by the Golgi stress response. Cell Struct. Funct. 2011, 36:1-12.
22. Roussel B.D., Kruppa A.J., Miranda E., Crowther D.C., Lomas D.A., Marciniak S.J. Endoplasmic reticulum dysfunction in neurological disease. Lancet Neurol. 2013, 12:105-118.
23. Sasaki J., Ishikawa K., Arita M., Taniguchi K. ACBD3-mediated recruitment of PI4KB to picornavirus RNA replication sites. EMBO J. 2012, 31:754-766.
24. Saudou F., Finkbeiner S., Devys D., Greenberg M.E. Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell 1998, 95:55-66.
25. Sbodio J.I., Hicks S.W., Simon D., Machamer C.E. GCP60 preferentially interacts with a caspase-generated golgin-160 fragment. J.Biol. Chem. 2006, 281:27924-27931.
26. Seredenina T., Luthi-Carter R. What have we learned from gene expression profiles in Huntington's disease?. Neurobiol. Dis. 2012, 45:83-98.
27. Seredenina T., Gokce O., Luthi-Carter R. Decreased striatal RGS2 expression is neuroprotective in Huntington's disease (HD) and exemplifies a compensatory aspect of HD-induced gene regulation. PLoS ONE 2011, 6:e22231.
28. Sohda M., Misumi Y., Yamamoto A., Yano A., Nakamura N., Ikehara Y. Identification and characterization of a novel Golgi protein, GCP60, that interacts with the integral membrane protein giantin. J.Biol. Chem. 2001, 276:45298-45306.
29. Subramaniam S., Sixt K.M., Barrow R., Snyder S.H. Rhes, a striatal specific protein, mediates mutant-huntingtin cytotoxicity. Science 2009, 324:1327-1330.
30. Trettel F., Rigamonti D., Hilditch-Maguire P., Wheeler V.C., Sharp A.H., Persichetti F., Cattaneo E., MacDonald M.E. Dominant phenotypes produced by the HD mutation in STHdh(Q111) striatal cells. Hum. Mol. Genet. 2000, 9:2799-2809.
31. Vargiu P., De Abajo R., Garcia-Ranea J.A., Valencia A., Santisteban P., Crespo P., Bernal J. The small GTP-binding protein, Rhes, regulates signal transduction from G protein-coupled receptors. Oncogene 2004, 23:559-568.
32. Velier J., Kim M., Schwarz C., Kim T.W., Sapp E., Chase K., Aronin N., DiFiglia M. Wild-type and mutant huntingtins function in vesicle trafficking in the secretory and endocytic pathways. Exp. Neurol. 1998, 152:34-40.